Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage InsurersGlobeNewsWire • 02/17/26
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation CompanyGlobeNewsWire • 01/13/26
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab EmiratesGlobeNewsWire • 12/17/25
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization ApprovalGlobeNewsWire • 12/03/25
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal ExoskeletonGlobeNewsWire • 11/17/25
Lifeward Achieves European Approval for Latest ReWalk ExoskeletonZacks Investment Research • 09/09/25
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal ExoskeletonGlobeNewsWire • 09/09/25
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council RegionGlobeNewsWire • 08/04/25
MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial ExpansionPRNewsWire • 07/07/25
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare BeneficiaryGlobeNewsWire • 06/24/25